News
AZ files for emergency use of COVID-19 antibody combo in US AstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent ...
AbbVie and Roche’s Venclexta is making headway as a second-line chronic lymphocytic leukaemia (CLL) treatment, and a new US filing could extend its use into the first-line setting. Roche has filed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback